ID ARC1B_HUMAN Reviewed; 372 AA. AC O15143; Q9BU00; DT 15-JUL-1998, integrated into UniProtKB/Swiss-Prot. DT 23-JAN-2007, sequence version 3. DT 02-DEC-2020, entry version 192. DE RecName: Full=Actin-related protein 2/3 complex subunit 1B; DE AltName: Full=Arp2/3 complex 41 kDa subunit; DE AltName: Full=p41-ARC; GN Name=ARPC1B {ECO:0000312|HGNC:HGNC:704}; Synonyms=ARC41; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, AND RP IDENTIFICATION IN THE ARP2/3 COMPLEX. RX PubMed=9230079; DOI=10.1083/jcb.138.2.375; RA Welch M.D., Depace A.H., Verma S., Iwamatsu A., Mitchison T.J.; RT "The human Arp2/3 complex is composed of evolutionarily conserved subunits RT and is localized to cellular regions of dynamic actin filament assembly."; RL J. Cell Biol. 138:375-384(1997). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=12853948; DOI=10.1038/nature01782; RA Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H., RA Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R., Wylie K., RA Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E., Fewell G.A., RA Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H., Sun H., RA Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A., Vanbrunt A., RA Nguyen C., Du F., Lamar B., Courtney L., Kalicki J., Ozersky P., RA Bielicki L., Scott K., Holmes A., Harkins R., Harris A., Strong C.M., RA Hou S., Tomlinson C., Dauphin-Kohlberg S., Kozlowicz-Reilly A., Leonard S., RA Rohlfing T., Rock S.M., Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., RA Strowmatt C., Latreille P., Miller N., Johnson D., Murray J., RA Woessner J.P., Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., RA Spieth J., Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., RA Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., RA Mardis E.R., Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E., RA Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K., Simms E., RA Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S., Baertsch R.A., RA Brent M.R., Keibler E., Flicek P., Bork P., Suyama M., Bailey J.A., RA Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R., Eddy S.R., RA McPherson J.D., Olson M.V., Eichler E.E., Green E.D., Waterston R.H., RA Wilson R.K.; RT "The DNA sequence of human chromosome 7."; RL Nature 424:157-164(2003). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Lung, Placenta, and Skin; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [4] RP PROTEIN SEQUENCE OF 2-20. RC TISSUE=Platelet; RX PubMed=12665801; DOI=10.1038/nbt810; RA Gevaert K., Goethals M., Martens L., Van Damme J., Staes A., Thomas G.R., RA Vandekerckhove J.; RT "Exploring proteomes and analyzing protein processing by mass spectrometric RT identification of sorted N-terminal peptides."; RL Nat. Biotechnol. 21:566-569(2003). RN [5] RP FUNCTION, SUBCELLULAR LOCATION, AND IDENTIFICATION IN THE ARP2/3 COMPLEX. RX PubMed=11741539; DOI=10.1016/s1097-2765(01)00393-8; RA Gournier H., Goley E.D., Niederstrasser H., Trinh T., Welch M.D.; RT "Reconstitution of human Arp2/3 complex reveals critical roles of RT individual subunits in complex structure and activity."; RL Mol. Cell 8:1041-1052(2001). RN [6] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=21269460; DOI=10.1186/1752-0509-5-17; RA Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., RA Bennett K.L., Superti-Furga G., Colinge J.; RT "Initial characterization of the human central proteome."; RL BMC Syst. Biol. 5:17-17(2011). RN [7] RP INVOLVEMENT IN PLTEID, AND VARIANTS PLTEID VAL-105 AND THR-238. RX PubMed=28368018; DOI=10.1038/ncomms14816; RA Kahr W.H., Pluthero F.G., Elkadri A., Warner N., Drobac M., Chen C.H., RA Lo R.W., Li L., Li R., Li Q., Thoeni C., Pan J., Leung G., RA Lara-Corrales I., Murchie R., Cutz E., Laxer R.M., Upton J., Roifman C.M., RA Yeung R.S., Brumell J.H., Muise A.M.; RT "Loss of the Arp2/3 complex component ARPC1B causes platelet abnormalities RT and predisposes to inflammatory disease."; RL Nat. Commun. 8:14816-14816(2017). RN [8] RP FUNCTION, AND SUBCELLULAR LOCATION. RX PubMed=29925947; DOI=10.1038/s41586-018-0237-5; RA Schrank B.R., Aparicio T., Li Y., Chang W., Chait B.T., Gundersen G.G., RA Gottesman M.E., Gautier J.; RT "Nuclear ARP2/3 drives DNA break clustering for homology-directed repair."; RL Nature 559:61-66(2018). CC -!- FUNCTION: Component of the Arp2/3 complex, a multiprotein complex that CC mediates actin polymerization upon stimulation by nucleation-promoting CC factor (NPF) (PubMed:11741539, PubMed:9230079). The Arp2/3 complex CC mediates the formation of branched actin networks in the cytoplasm, CC providing the force for cell motility (PubMed:11741539, CC PubMed:9230079). In addition to its role in the cytoplasmic CC cytoskeleton, the Arp2/3 complex also promotes actin polymerization in CC the nucleus, thereby regulating gene transcription and repair of CC damaged DNA (PubMed:29925947). The Arp2/3 complex promotes homologous CC recombination (HR) repair in response to DNA damage by promoting CC nuclear actin polymerization, leading to drive motility of double- CC strand breaks (DSBs) (PubMed:29925947). {ECO:0000269|PubMed:11741539, CC ECO:0000269|PubMed:29925947, ECO:0000269|PubMed:9230079}. CC -!- SUBUNIT: Component of the Arp2/3 complex composed of ACTR2/ARP2, CC ACTR3/ARP3, ARPC1B/p41-ARC, ARPC2/p34-ARC, ARPC3/p21-ARC, ARPC4/p20-ARC CC and ARPC5/p16-ARC. {ECO:0000269|PubMed:11741539, CC ECO:0000269|PubMed:9230079}. CC -!- INTERACTION: CC O15143; O15145: ARPC3; NbExp=11; IntAct=EBI-1044647, EBI-351829; CC O15143; Q5ZTM4: legK2; Xeno; NbExp=3; IntAct=EBI-1044647, EBI-16631153; CC -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton CC {ECO:0000269|PubMed:11741539, ECO:0000269|PubMed:9230079}. Nucleus CC {ECO:0000269|PubMed:29925947}. CC -!- DISEASE: Platelet abnormalities with eosinophilia and immune-mediated CC inflammatory disease (PLTEID) [MIM:617718]: An autosomal recessive CC disorder characterized by platelet abnormalities, vasculitis, CC eosinophilia, and predisposition to inflammatory diseases. CC {ECO:0000269|PubMed:28368018}. Note=The disease is caused by mutations CC affecting the gene represented in this entry. CC -!- SIMILARITY: Belongs to the WD repeat ARPC1 family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AF006084; AAB64189.1; -; mRNA. DR EMBL; AC004922; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; BC002562; AAH02562.1; -; mRNA. DR EMBL; BC002988; AAH02988.2; -; mRNA. DR EMBL; BC007555; AAH07555.1; -; mRNA. DR CCDS; CCDS5661.1; -. DR RefSeq; NP_005711.1; NM_005720.3. DR RefSeq; XP_006715888.1; XM_006715825.1. DR RefSeq; XP_006715889.1; XM_006715826.1. DR PDB; 6UHC; EM; 3.90 A; C=1-372. DR PDB; 6YW6; EM; 4.20 A; C=1-372. DR PDBsum; 6UHC; -. DR PDBsum; 6YW6; -. DR SMR; O15143; -. DR BioGRID; 115402; 86. DR CORUM; O15143; -. DR DIP; DIP-41254N; -. DR IntAct; O15143; 56. DR MINT; O15143; -. DR STRING; 9606.ENSP00000389631; -. DR ChEMBL; CHEMBL4295656; -. DR DrugBank; DB08236; (2S)-2-(3-bromophenyl)-3-(5-chloro-2-hydroxyphenyl)-1,3-thiazolidin-4-one. DR DrugBank; DB08235; N-[2-(2-methyl-1H-indol-3-yl)ethyl]thiophene-2-carboxamide. DR iPTMnet; O15143; -. DR PhosphoSitePlus; O15143; -. DR SwissPalm; O15143; -. DR BioMuta; ARPC1B; -. DR EPD; O15143; -. DR jPOST; O15143; -. DR MassIVE; O15143; -. DR MaxQB; O15143; -. DR PaxDb; O15143; -. DR PeptideAtlas; O15143; -. DR PRIDE; O15143; -. DR ProteomicsDB; 48468; -. DR Antibodypedia; 1378; 202 antibodies. DR DNASU; 10095; -. DR Ensembl; ENST00000427217; ENSP00000403211; ENSG00000130429. DR Ensembl; ENST00000431816; ENSP00000398110; ENSG00000130429. DR Ensembl; ENST00000451682; ENSP00000389631; ENSG00000130429. DR Ensembl; ENST00000455009; ENSP00000410238; ENSG00000130429. DR Ensembl; ENST00000458033; ENSP00000388802; ENSG00000130429. DR Ensembl; ENST00000645391; ENSP00000494033; ENSG00000130429. DR Ensembl; ENST00000646101; ENSP00000496599; ENSG00000130429. DR GeneID; 10095; -. DR KEGG; hsa:10095; -. DR UCSC; uc003upz.4; human. DR CTD; 10095; -. DR DisGeNET; 10095; -. DR EuPathDB; HostDB:ENSG00000130429.12; -. DR GeneCards; ARPC1B; -. DR HGNC; HGNC:704; ARPC1B. DR HPA; ENSG00000130429; Tissue enhanced (blood). DR MalaCards; ARPC1B; -. DR MIM; 604223; gene. DR MIM; 617718; phenotype. DR neXtProt; NX_O15143; -. DR OpenTargets; ENSG00000130429; -. DR PharmGKB; PA24998; -. DR eggNOG; KOG1523; Eukaryota. DR GeneTree; ENSGT00950000183183; -. DR HOGENOM; CLU_034396_1_0_1; -. DR InParanoid; O15143; -. DR OMA; KWVQVHE; -. DR OrthoDB; 848569at2759; -. DR PhylomeDB; O15143; -. DR TreeFam; TF315041; -. DR PathwayCommons; O15143; -. DR Reactome; R-HSA-2029482; Regulation of actin dynamics for phagocytic cup formation. DR Reactome; R-HSA-3928662; EPHB-mediated forward signaling. DR Reactome; R-HSA-5663213; RHO GTPases Activate WASPs and WAVEs. DR Reactome; R-HSA-9664422; FCGR3A-mediated phagocytosis. DR SignaLink; O15143; -. DR SIGNOR; O15143; -. DR BioGRID-ORCS; 10095; 9 hits in 839 CRISPR screens. DR ChiTaRS; ARPC1B; human. DR GeneWiki; ARPC1B; -. DR GenomeRNAi; 10095; -. DR Pharos; O15143; Tbio. DR PRO; PR:O15143; -. DR Proteomes; UP000005640; Chromosome 7. DR RNAct; O15143; protein. DR Bgee; ENSG00000130429; Expressed in monocyte and 239 other tissues. DR ExpressionAtlas; O15143; baseline and differential. DR Genevisible; O15143; HS. DR GO; GO:0015629; C:actin cytoskeleton; TAS:ProtInc. DR GO; GO:0005885; C:Arp2/3 protein complex; IDA:FlyBase. DR GO; GO:0005829; C:cytosol; TAS:Reactome. DR GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB. DR GO; GO:0005925; C:focal adhesion; HDA:UniProtKB. DR GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell. DR GO; GO:0036284; C:tubulobulbar complex; IEA:Ensembl. DR GO; GO:0003779; F:actin binding; IEA:UniProtKB-KW. DR GO; GO:0044877; F:protein-containing complex binding; IEA:Ensembl. DR GO; GO:0005200; F:structural constituent of cytoskeleton; IDA:FlyBase. DR GO; GO:0034314; P:Arp2/3 complex-mediated actin nucleation; IDA:FlyBase. DR GO; GO:0048013; P:ephrin receptor signaling pathway; TAS:Reactome. DR GO; GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome. DR GO; GO:0032355; P:response to estradiol; IEA:Ensembl. DR GO; GO:0043627; P:response to estrogen; IEA:Ensembl. DR Gene3D; 2.130.10.10; -; 1. DR InterPro; IPR030141; ARC1B. DR InterPro; IPR017383; ARPC1. DR InterPro; IPR015943; WD40/YVTN_repeat-like_dom_sf. DR InterPro; IPR001680; WD40_repeat. DR InterPro; IPR017986; WD40_repeat_dom. DR InterPro; IPR036322; WD40_repeat_dom_sf. DR PANTHER; PTHR10709; PTHR10709; 1. DR PANTHER; PTHR10709:SF10; PTHR10709:SF10; 1. DR Pfam; PF00400; WD40; 2. DR PIRSF; PIRSF038093; ARP2/3_su1; 1. DR SMART; SM00320; WD40; 6. DR SUPFAM; SSF50978; SSF50978; 1. DR PROSITE; PS50082; WD_REPEATS_2; 1. DR PROSITE; PS50294; WD_REPEATS_REGION; 1. PE 1: Evidence at protein level; KW 3D-structure; Actin-binding; Cytoplasm; Cytoskeleton; KW Direct protein sequencing; Disease mutation; Nucleus; Polymorphism; KW Reference proteome; Repeat; WD repeat. FT INIT_MET 1 FT /note="Removed" FT /evidence="ECO:0000269|PubMed:12665801" FT CHAIN 2..372 FT /note="Actin-related protein 2/3 complex subunit 1B" FT /id="PRO_0000050855" FT REPEAT 6..45 FT /note="WD 1" FT REPEAT 50..89 FT /note="WD 2" FT REPEAT 94..135 FT /note="WD 3" FT REPEAT 140..179 FT /note="WD 4" FT REPEAT 242..280 FT /note="WD 5" FT REPEAT 324..367 FT /note="WD 6" FT VARIANT 37 FT /note="K -> N (in dbSNP:rs1045012)" FT /id="VAR_014477" FT VARIANT 105 FT /note="A -> V (in PLTEID; unknown pathological FT significance)" FT /evidence="ECO:0000269|PubMed:28368018" FT /id="VAR_080353" FT VARIANT 238 FT /note="A -> T (in PLTEID; unknown pathological FT significance; dbSNP:rs147238850)" FT /evidence="ECO:0000269|PubMed:28368018" FT /id="VAR_080354" SQ SEQUENCE 372 AA; 40950 MW; 1939F5B63D40BD27 CRC64; MAYHSFLVEP ISCHAWNKDR TQIAICPNNH EVHIYEKSGA KWTKVHELKE HNGQVTGIDW APESNRIVTC GTDRNAYVWT LKGRTWKPTL VILRINRAAR CVRWAPNENK FAVGSGSRVI SICYFEQEND WWVCKHIKKP IRSTVLSLDW HPNNVLLAAG SCDFKCRIFS AYIKEVEERP APTPWGSKMP FGELMFESSS SCGWVHGVCF SASGSRVAWV SHDSTVCLAD ADKKMAVATL ASETLPLLAL TFITDNSLVA AGHDCFPVLF TYDAAAGMLS FGGRLDVPKQ SSQRGLTARE RFQNLDKKAS SEGGTAAGAG LDSLHKNSVS QISVLSGGKA KCSQFCTTGM DGGMSIWDVK SLESALKDLK IK //